FMR LLC

Position in OBIO — Orchestra BioMed Holdings, Inc.

CIK 315066 BOSTON, MA

Position in OBIO

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$76,823

+$72,412 QoQ

Shares Held

18,076

+998.2% QoQ

Ownership

0.030%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

10 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

FMR LLC holds $49,682,018,247 across 354 Biotechnology names. OBIO ranks #251 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	14,579,166	$4,823,808,652
2	ARGX	Argenx SE	4,991,034	$3,644,702,577
3	MRNA	Moderna, Inc.	45,672,024	$2,320,138,818
4	ROIV	Roivant Sciences Ltd.	77,981,253	$2,160,080,705
5	INSM	INSMED Inc	13,160,167	$2,151,950,504
6	IONS	Ionis Pharmaceuticals Inc	24,556,637	$1,843,957,869
7	RPRX	Royalty Pharma plc	25,152,242	$1,206,553,046
8	REGN	Regeneron Pharmaceuticals, Inc.	1,518,192	$1,173,015,865

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$76,823	18,076	+998.2%	Shares	Defined	2026-05-15
2025-06-30	$4,411	1,646	+50.2%	Shares	Defined	2025-08-14
2025-03-31	$4,690	1,096	+8.8%	Shares	Defined	2025-05-12
2024-12-31	$4,028	1,007	-65.0%	Shares	Defined	2025-02-13
2024-09-30	$14,777	2,875	+530.5%	Shares	Defined	2024-11-13
2024-06-30	$3,716	456	-43.1%	Shares	Defined	2024-08-13
2024-03-31	$4,226	802	-76.1%	Shares	Defined	2024-05-13
2023-12-31	$30,576	3,349	+47.8%	Shares	Defined	2024-02-13
2023-09-30	$19,759	2,266	+501.1%	Shares	Defined	2023-11-13
2023-06-30	$2,639	377	—	Shares	Defined	2023-08-11
No filing history on record for this holder in this stock.